Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p

被引:100
|
作者
Li, Xiaoping [1 ]
Yang, Bo [1 ]
Ren, Haixia [2 ]
Xiao, Ting [3 ]
Zhang, Liang [1 ]
Li, Lei [1 ]
Li, Mingjiang [1 ]
Wang, Xuhui [1 ]
Zhou, Honggang [4 ]
Zhang, Weidong [1 ]
机构
[1] Tianjin First Cent Hosp, Dept Thorac Surg, Tianjin 300192, Peoples R China
[2] Tianjin First Cent Hosp, Dept Pharm, Tianjin 300192, Peoples R China
[3] Nankai Univ, State Key Lab Med Chem Biol, Coll Pharm, Tianjin 300350, Peoples R China
[4] Nankai Univ, Tianjin Int Joint Acad Biomed, Coll Pharm, Tianjin Key Lab Mol Drug Res, Tianjin 300350, Peoples R China
关键词
PACLITAXEL; RESISTANCE; EFFICACY;
D O I
10.1038/s41419-019-2180-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this study, we identified a novel circRNA, circ_0002483, and further investigated its functions in the progression and Taxol resistance of NSCLC. We found that circ_0002483 was expressed at low levels in NSCLC tissues and cell lines. Functional assays indicated that circ_0002483 overexpression significantly inhibited NSCLC cell proliferation and invasion in vitro and in vivo and enhanced the sensitivity of NSCLC cells to Taxol. Mechanistically, circ_0002483 was identified to sponge multiple miRNAs including miR-182-5p (also named miR-182), miR-520q-3p, miR-582-3p, miR-587, and miR-655. In addition, circ_0002483 was also demonstrated to regulate the expression of GRB2, FOXO1, and FOXO3, three target genes of miR-182-5p, by sponging miR-182-5p. Circ_0002483 was demonstrated to inhibit NSCLC progression in vitro and in vivo and enhanced the sensitivity of NSCLC cells to Taxol by sponging miR-182-5p to release the inhibition on GRB2, FOXO1, and FOXO3 mRNAs.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Downregulated expression of hsa_circ_0037515 and hsa_circ_0037516 as novel biomarkers for non-small cell lung cancer
    Zhao, Dunmei
    Liu, Honggang
    Liu, Huachao
    Zhang, Xueqing
    Zhang, Meng
    Kolluri, Vijay Kumar
    Feng, Xulong
    He, Zhenglei
    Wang, Minghua
    Zhu, Tingan
    Yan, Xiaolong
    Zhou, Yinghui
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (01): : 162 - 170
  • [32] MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN
    Wang, Huimin
    Ma, Zhongliang
    Liu, Xiaomin
    Zhang, Caiyan
    Hu, Yanping
    Ding, Lei
    Qi, Pengfei
    Wang, Ju
    Lu, Shengdi
    Li, Yanli
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 : 1103 - 1111
  • [33] Exosome-Derived hsa_circ_0005741 Promotes Malignant Progression of Non-Small Cell Lung Cancer by Mediating the MiR-1251-5p/YAP1 Pathway
    He, Yihua
    Wu, Shuting
    Zhi, Jiazhi
    Wei, Hailin
    Chen, Jianwei
    Lin, Junping
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (07): : 3791 - 3802
  • [34] Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway
    Huang, Ma-Sha
    Liu, Jun-Yan
    Xia, Xiao-Bo
    Liu, Ying-Zi
    Li, Xi
    Yin, Ji-Ye
    Peng, Ding-Bo
    Wu, Lin
    Zhang, Wei
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [35] miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer
    Gao, Zhao-jia
    Yuan, Wei-dong
    Yuan, Jun-qiang
    Yuan, Kai
    Wang, Yong
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (05) : 700 - 705
  • [36] Hsa_circ_0079530 promotes cell proliferation and invasion in non-small cell lung cancer
    Li, Jipeng
    Wang, Jianhua
    Chen, Zhe
    Chen, Yin
    Jin, Mingwei
    GENE, 2018, 665 : 1 - 5
  • [37] Hsa_circ_0033155: A potential novel biomarker for non-small cell lung cancer
    Gu, Xiaohua
    Wang, Gang
    Shen, Hui
    Fei, Xiaoyun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (04) : 3220 - 3226
  • [38] Depletion of circ-BIRC6, a circular RNA, suppresses non-small cell lung cancer progression by targeting miR-4491
    Jin, Zhu
    Gao, Baoan
    Gong, Yuan
    Guan, Li
    BIOSCIENCE TRENDS, 2020, 14 (06) : 399 - 407
  • [39] Circ_0058608 contributes to the progression and taxol resistance of non-small cell lung cancer by sponging miR-1299 to upregulate GBP1
    Xuan, Xianglan
    Wang, Zhiguang
    Wang, Yayan
    ANTI-CANCER DRUGS, 2023, 34 (01) : 103 - 114
  • [40] MiR-3074-5p suppresses non-small cell lung cancer progression by targeting the YWHAZ/Hsp27 axis
    Dong, Nian
    Gu, Wen-Wen
    Yang, Long
    Lian, Wen-Bo
    Jiang, Juan
    Zhu, Hai-Jun
    Chen, Cheng-Shui
    Wang, Bei-Bei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 138